MICHELLE WINSOR: Open Payments
NPI 1467700823 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,768 in 96 payments from 18 companies in 2025. Trend: 2023 $1,891 · 2024 $1,960 · 2025 $1,768
Food & beverage: $1,758Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $456 |
| Novartis Pharmaceuticals Corporation | 15 | $231 |
| Incyte Corporation | 11 | $189 |
| GENZYME CORPORATION | 8 | $159 |
| Regeneron Healthcare Solutions, Inc. | 5 | $158 |
| Novo Nordisk Inc | 2 | $103 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $66 |
| Janssen Biotech, Inc. | 3 | $66 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| PFIZER INC. | 3 | $55 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, COSENTYX, OPZELURA, Wegovy, ILUMYA, TREMFYA.
Industry payments across NY — which companies pay providers there.
